WHO, the Global Fund, and medical malpractice in malaria treatment. by White, N, Nosten, F, Björkman, A, Marsh, K, Snow, R

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (malarone) when taken as chemoprophylaxis by Mita, T, Ashton, M, Lindegardh, N, Bergqvist, Y, Nivelius, S, Johansson, I, Bjorkman, A

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis by Mita, T, Ashton, M, Lindegardh, N, Bergqvist, Y, Nivelius, S, Johansson, I, Bjorkman, A

Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis. by Thapar, M, Ashton, M, Lindegårdh, N, Bergqvist, Y, Nivelius, S, Johansson, I, Björkman, A

Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. by Blessborn, D, Römsing, S, Annerberg, A, Sundquist, D, Björkman, A, Lindegardh, N, Bergqvist, Y

pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine. by Veiga, M, Ferreira, P, Malmberg, M, Jörnhagen, L, Björkman, A, Nosten, F, Gil, J

Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial. by Ursing, J, Kofoed, P, Rodrigues, A, Blessborn, D, Thoft-Nielsen, R, Björkman, A, Rombo, L

Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. by Malmberg, M, Ferreira, P, Tarning, J, Ursing, J, Ngasala, B, Björkman, A, Mårtensson, A, Gil, J

Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent by Jelinek T, Hatz C, Gascon J, Björkman A, Bisoffi Z, Behrens RH, Legros F, Mühlberger N, Voltersvik P

Get full text

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. by Färnert, A, Lindberg, J, Gil, P, Swedberg, G, Berqvist, Y, Thapar, M, Lindegårdh, N, Berezcky, S, Björkman, A

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine in combination treatment of uncomplicated falciparum malaria in pediatric patients by Hietala, S, Martensson, A, Ngasala, B, Dahlstrom, S, Lindegardh, N, Annerberg, A, Premji, Z, Farnert, A, Gil, P, Bjorkman, A, Ashton, M

Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. by Veiga, M, Ferreira, P, Jornhagen, L, Malmberg, M, Kone, A, Schmidt, B, Petzold, M, Bjorkman, A, Nosten, F, Gil, J

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. by Hietala, S, Mårtensson, A, Ngasala, B, Dahlström, S, Lindegårdh, N, Annerberg, A, Premji, Z, Färnert, A, Gil, P, Björkman, A, Ashton, M

Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms. by Jovel, I, Ferreira, P, Veiga, M, Malmberg, M, Mårtensson, A, Kaneko, A, Zakeri, S, Murillo, C, Nosten, F, Björkman, A, Ursing, J

Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in... by Ngasala, B, Malmberg, M, Carlsson, A, Ferreira, P, Petzold, MG, Blessborn, D, Bergqvist, Y, Gil, J, Premji, Z, Björkman, A, Mårtensson, A

Safety and efficacy of the Russian COVID-19 vaccine: more information needed by Bucci, E, Andreev, K, Björkman, A, Calogero, RA, Carafoli, E, Carninci, P, Castagnoli, P, Cossarizza, A, Mussini, C, Guerin, P, Lipworth, B, Sbardella, G, Stocki, T, Tuosto, L, van Tulleken, C, Viola, A

A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact o... by Morris, U, Msellem, M, Mkali, H, Islam, A, Aydin-Schmidt, B, Jovel, I, Shija, S, Khamis, M, Ali, S, Hodzic, L, Magnusson, E, Poirot, E, Bennett, A, Sachs, M, Tarning, J, Mårtensson, A, Ali, A, Björkman, A

Cooperation in countering artemisinin resistance in Africa: learning from COVID-19 by Rosenthal, PJ, Björkman, A, Dhorda, M, Djimde, A, Dondorp, AM, Gaye, O, Guerin, PJ, Juma, E, Kwiatkowski, DP, Merson, L, Ntoumi, F, Price, RN, Raman, J, Roos, DS, Ter Kuile, F, Tinto, H, Tomko, SS, White, NJ, Barnes, KI

Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives by Flegg, J, Guérin, P, Nosten, F, Ashley, E, Phyo, A, Dondorp, A, Fairhurst, R, Socheat, D, Borrmann, S, Björkman, A, Mårtensson, A, Mayxay, M, Newton, P, Bethell, D, Se, Y, Noedl, H, Diakite, M, Djimde, A, Hien, T, White, N, Stepniewska, K

Efficacy of single dose primaquine with artemisinin combination therapy on P. falciparum gametocytes and transmission: A WWARN individual patient meta-analysis by Stepniewska, K, Humphreys, GS, Gonçalves, BP, Craig, E, Gosling, R, Guerin, PJ, Price, RN, Barnes, KI, Raman, J, Smit, MR, D'Alessandro, U, Stone, WJR, Bjorkman, A, Samuels, AM, Arroyo-Arroyo, MI, Bastiaens, GJH, Brown, JM, Dicko, A, El-Sayed, BB, Elzaki, S-EG, Eziefula, AC, Kariuki, S, Kwambai, TK, Maestre, AE, Martensson, A, Mosha, D, Mwaiswelo, RO, Ngasala, BE, Okebe, J, Roh, ME, Sawa, P, Tiono, AB, Chen, I, Drakeley, CJ, Bousema, T